News|Articles|February 13, 2019

Firdapse for LEMS in Adults

Author(s)Drew Boxler

Firdapse (amifampridine, Catalyst Pharmaceuticals)

Indications: treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults.

Dosage: 15 mg to 30 mg daily taken orally in divided doses (3 to 4 times daily); increased by 5mg daily every 3-4 days, not to exceed 80mg daily

Contraindications: History of seizures; hypersensitivity to amifampridine or another aminopyridine

Click here for more prescribing information

Newsletter

Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.


Latest CME